News about Market

Sino Biopharma and AstraZeneca Sign Licensing Deal for TQC3721

Sino Biopharmaceutical has signed an exclusive licensing agreement with AstraZeneca to develop, manufacture, and commercialise TQC3721, a novel PDE3/4 inhibitor for respiratory diseases.

Market | 09/07/2026 | By News Bureau |  143

Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili

Biocon has published pivotal clinical data supporting the effectiveness of Yesafili, its Food and Drug Administration (FDA)-approved interchangeable aflibercept biosimilar, demonstrating comparable safety, efficacy, and immunogenicity.

Market | 09/07/2026 | By News Bureau |  196

Astex and Genentech Partner to Develop Precision Small Molecule Therapies for Breast Cancer

Astex Pharmaceuticals has entered into an exclusive global research and licensing agreement with Genentech to advance small molecule therapies for breast cancer. The deal includes a USD 25 million upfront payment to Astex and potential milestone payments exceeding USD 490 million, alongside tiered royalties on future product sales.

Market | 07/07/2026 | By News Bureau |  130

Sanyou Bio, Baiyunshan Xihe Partner to Advance AI-Driven Radiopharmaceutical Development

Sanyou Biopharmaceuticals and Guangzhou Baiyunshan Xihe Health Pharmaceutical have entered a strategic partnership to co-develop innovative radiopharmaceuticals and radiodiagnostic products.

Market | 07/07/2026 | By News Bureau |  145

Astex Partners with Genentech on Breast Cancer Therapy Research

Astex has entered an exclusive research and licensing agreement with Genentech for a breast cancer therapy program, with potential deal value exceeding USD 490 million plus tiered royalties.

Market | 07/07/2026 | By News Bureau

Arima Genomics Partners with Active Motif to Expand Global Access to Hi-C Research Solutions

Arima Genomics has granted Active Motif exclusive distribution rights for its Hi-C research kits and services, supporting broader adoption of 3D genomics tools while advancing Arima's clinical cancer diagnostics strategy.

Market | 06/07/2026 | By News Bureau |  115

Sofinnova Partners Announces Myricx Bio Agrees to Be Acquired by Novartis

Sofinnova Partners announced that portfolio company Myricx Bio has agreed to be acquired by Novartis, strengthening the company's oncology pipeline and ADC capabilities.

Market | 06/07/2026 | By Akanki |  122

Emcure's Marcan Pharma to Acquire Remaining Stake in Mantra Pharma

Emcure Pharmaceuticals' subsidiary Marcan Pharmaceuticals has signed agreements to acquire the remaining Class E Special Shares of Canada's Mantra Pharma, making the company a wholly owned subsidiary.

Market | 06/07/2026 | By News Bureau |  151

Oliva Therapeutics to Commercially Launch Amerithroid for Hypothyroidism Treatment

Oliva Therapeutics is set to launch Amerithroid, a US-manufactured desiccated thyroid extract developed in partnership with Jerome Stevens Pharmaceuticals, strengthening its endocrine care portfolio with a naturally derived treatment for hypothyroidism.

Market | 06/07/2026 | By News Bureau |  137

Glenmark Pharmaceuticals Launches Olanzapine for Injection 10 mg/vial Single-Dose Vial in US

Glenmark Pharmaceuticals Inc., USA has launched Olanzapine for Injection 10 mg/vial, a bioequivalent and therapeutically equivalent generic to Zyprexa IntraMuscular Injection.

Market | 06/07/2026 | By Akanki